Jeremy L. Davis
Staff Clinician
Center for Cancer Research
National Cancer Institute
United States of America
Biography
Dr. Davis trained in Complex General Surgical Oncology at Memorial Sloan Kettering Cancer Center with an interest in gastric and hepato-pancreato-biliary tumors. He is board certified in both Complex General Surgical Oncology and General Surgery. Dr. Davis completed his surgical training at Indiana University during which time he dedicated three years as a research fellow in Surgical Oncology and Immunotherapy at NCI.
Research Interest
Gastric cancer, Pancreatic cancer, Hepatic metastasectomy, Minimally-invasive and robotic surgery
Publications
-
Feingold PL, Kwong ML, Davis JL, Rudloff U. Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review. Journal of surgical oncology. 2016 Nov 1.
-
McDuffie LA, Sabesan A, Allgäeuer M, Xin L, Koh C, Heller T, Davis JL, Raffeld M, Miettienen M, Quezado M, Rudloff U. β-Catenin activation in fundic gland polyps, gastric cancer and colonic polyps in families afflicted by ‘gastric adenocarcinoma and proximal polyposis of the stomach’(GAPPS). Journal of clinical pathology. 2016 Jul 12:jclinpath-2016.
-
Davis JL, Selby LV, Chou JF, Schattner M, Ilson DH, Capanu M, Brennan MF, Coit DG, Strong VE. Patterns and predictors of weight loss after gastrectomy for cancer. Annals of surgical oncology. 2016 May 1;23(5):1639-45.
